CASI Pharmaceuticals, Inc. (CASIF) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$48.06M | -22.4% |
| 2024 | -$39.26M | -45.6% |
| 2023 | -$26.96M | +34.3% |
| 2022 | -$41.01M | -11.9% |
| 2021 | -$36.65M | +24.1% |
| 2020 | -$48.29M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$48.06M | -22.4% |
| 2024 | -$39.26M | -45.6% |
| 2023 | -$26.96M | +34.3% |
| 2022 | -$41.01M | -11.9% |
| 2021 | -$36.65M | +24.1% |
| 2020 | -$48.29M | — |